Rare (and Rarely Diagnosed) Diseases in Ophthalmology - Summary - MDSpire

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

Regulatory policies, combined with better screening tools, can broaden access to needed treatments

  • By

  • Neel Desai

  • January 21, 2026

  • 8 min

Share

Objective:

Emphasize the significance of the Orphan Drug Act in the context of rare diseases.

Key Findings:
  • Add a finding about the necessity of clinician education to combat underdiagnosis.
Interpretation:

Strengthen the urgency of addressing barriers to treatment.

Limitations:
  • Include the impact of high drug costs on patient access.
Conclusion:

Stress the importance of collaboration among stakeholders to enhance patient outcomes.

Original Source(s)

Rare (and Rarely Diagnosed) Diseases in Ophthalmology

  • by Neel Desai

  • January 21, 2026

Related Content

Challenging Refractions

Dr. McKinnis describes what to do when visual acuity alone does not fully capture visual quality.

HPV Linked to Thyroid Eye Disease

Patients with the eye disorder were more likely to have had low-risk HPV before hyperthyroidism diagnosis.

Is This the New Norm?: <br>Is the End of Specialty CL Labs the New Norm?</br>